J Am Acad Child Adolesc Psychiatry. 1990 Sep;29(5):702-9.

Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder.

Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD.

Source

Department of Psychology, University of Rochester, NY 14627.

Abstract

Forty-eight attention deficit disorder patients, 12 to 18 years old and without previous stimulant therapy, received a double-blind trial of methylphenidate and placebo for 3 weeks each. Stimulant treatment produced mild side effects and weight reduction. Methylphenidate significantly reduced teachers' and parents' ratings of hyperactivity, inattention, and oppositionality. In addition, patients rated themselves as clinically improved and reported elevated subjective mood during stimulant therapy. Treatment benefits were comparable for patients with and without concurrent conduct or oppositional disorder as well as those with and without past or present depressive disorders. These results support the continued effectiveness of stimulant therapy for attention deficit disorder in adolescence. However, the magnitude of clinical effectiveness reported was smaller than previously found in younger patients.

Comment in

J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):171-2.

PMID:: 2228922; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Methylphenidate

Grant Support

MH38118/MH/NIMH NIH HHS/United States

LinkOut - more resources

Full Text Sources

Medical

Attention Deficit Hyperactivity Disorder - MedlinePlus Health Information

Molecular Biology Databases

METHYLPHENIDATE - HSDB

Supplemental Content

Save items

Related citations in PubMed

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. [Pediatrics. 1999]
A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J. Pediatrics. 1999 Apr; 103(4):e43.
Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. [BMC Psychiatry. 2004]
Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
Akhondzadeh S, Mohammadi MR, Khademi M. BMC Psychiatry. 2004 Apr 8; 4:9. Epub 2004 Apr 8.
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. [Pediatrics. 2006]
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Pediatrics. 2006 Sep; 118(3):e704-10.
Review [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]. [Encephale. 2005]
Review [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP. Encephale. 2005 May-Jun; 31(3):337-48.
Review A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. [Health Technol Assess. 2006]
Review A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R. Health Technol Assess. 2006 Jul; 10(23):iii-iv, xiii-146.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Clinical effects of a controlled trial of methylphenidate on adolescents with at...
Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder.
J Am Acad Child Adolesc Psychiatry. 1990 Sep ;29(5):702-9.

PubMed
VIP in construction: systematic development and evaluation of a multifaceted hea...
VIP in construction: systematic development and evaluation of a multifaceted health programme aiming to improve physical activity levels and dietary patterns among construction workers.
BMC Public Health. 2012 Jan 30 ;12:89.

PubMed
New influenza vaccines: promises, perils, and pitfalls.
New influenza vaccines: promises, perils, and pitfalls.
Vaccine. 2012 Feb 1 ;30(6):983-4.

PubMed
The DSM-III-R field trial of disruptive behavior disorders.
The DSM-III-R field trial of disruptive behavior disorders.
J Am Acad Child Adolesc Psychiatry. 1990 Sep ;29(5):690-7.

PubMed
Hepatitis C virus to hepatocellular carcinoma.
Hepatitis C virus to hepatocellular carcinoma.
Infect Agent Cancer. 2012 Jan 30 ;7(1):2.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: